Literature DB >> 12023946

Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.

Mario Marchi1, Luca Raiteri, Francesca Risso, Annalisa Vallarino, Andrea Bonfanti, Angela Monopoli, Ennio Ongini, Maurizio Raiteri.   

Abstract

1. The effects of adenosine A2A and A1 receptor activation on the release of glutamate were studied in rat cerebral cortex synaptosomes exposed in superfusion to adenosine receptor ligands. 2. Adenosine (0.1 microM) produced a significant potentiation of the Ca2+-dependent K+ (15 mM)-evoked [3H]-D-aspartate overflow (20.4+/-3.5%), which was blocked by A2A blocker SCH58261 (0.1 microM). At higher concentrations (10 - 1000 microM) adenosine inhibited in a DPCPX-sensitive manner the Ca2+-dependent K+-evoked [3H]-D-aspartate overflow. The inhibitory effect of adenosine at 1000 microM was significantly increased by SCH58261. This inhibition was antagonized by 1 microM DPCPX. Adenosine did not produce any effect on basal release. 3. The A2A receptor agonist CGS 21680 was ineffective on basal release, but stimulated the Ca2+-dependent K+-evoked overflow of [3H]-D-aspartate (EC50 approximately 1 pM). The effect of 0.01 nM CGS 21680 was totally sensitive to the A2A receptor antagonist SCH58261 (IC50 approximately 5 nM). 4. The A1 receptor agonist CCPA inhibited the Ca2+-dependent K+-evoked [3H]-D-aspartate overflow (EC50 approximately 20 nM). The effect of 100 nM CCPA was abolished by 100 nM of the A1 receptor antagonist DPCPX. 5. The K+ (15 mM)-evoked overflow of endogenous glutamate was enhanced by CGS 21680 (0.01 nM) and inhibited by CCPA (0.1 microM). The effect of CGS 21680 was abolished by SCH58261 (0.1 microM) and that of CCPA by DPCPX (0.1 microM). 6. It is concluded that adenosine and adenosine receptor agonists modulate glutamate release by activating inhibitory A1 and excitatory A2A receptors present on glutamatergic terminals of the rat cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023946      PMCID: PMC1573357          DOI: 10.1038/sj.bjp.0704712

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals.

Authors:  R A Cunha; J A Ribeiro
Journal:  Neuropharmacology       Date:  2000-04-27       Impact factor: 5.250

Review 2.  Central adenosine A(2A) receptors: an overview.

Authors:  J L Moreau; G Huber
Journal:  Brain Res Brain Res Rev       Date:  1999-12

3.  A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.

Authors:  J F Chen; Z Huang; J Ma; J Zhu; R Moratalla; D Standaert; M A Moskowitz; J S Fink; M A Schwarzschild
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

Review 4.  Synaptosomes still viable after 25 years of superfusion.

Authors:  L Raiteri; M Raiteri
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

5.  [3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies.

Authors:  B B Fredholm; K Lindström; S Dionisotti; E Ongini
Journal:  J Neurochem       Date:  1998-03       Impact factor: 5.372

Review 6.  Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?

Authors:  D K von Lubitz
Journal:  Eur J Pharmacol       Date:  1999-04-23       Impact factor: 4.432

Review 7.  Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators.

Authors:  J A Ribeiro
Journal:  Eur J Pharmacol       Date:  1999-06-30       Impact factor: 4.432

8.  The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices.

Authors:  G C Bennett; M R Boarder
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

9.  Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats.

Authors:  A Monopoli; G Lozza; A Forlani; A Mattavelli; E Ongini
Journal:  Neuroreport       Date:  1998-12-01       Impact factor: 1.837

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

View more
  25 in total

Review 1.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

2.  Adenosine A1 receptors decrease thalamic excitation of inhibitory and excitatory neurons in the barrel cortex.

Authors:  D E Fontanez; J T Porter
Journal:  Neuroscience       Date:  2005-12-15       Impact factor: 3.590

Review 3.  Caffeine and the control of cerebral hemodynamics.

Authors:  Dale A Pelligrino; Hao-Liang Xu; Francesco Vetri
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Modulation of synaptic transmission by adenosine in layer 2/3 of the rat visual cortex in vitro.

Authors:  N M Bannon; P Zhang; V Ilin; M Chistiakova; M Volgushev
Journal:  Neuroscience       Date:  2013-12-16       Impact factor: 3.590

Review 5.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

6.  Caffeine attenuates lipopolysaccharide-induced neuroinflammation.

Authors:  Holly M Brothers; Yannick Marchalant; Gary L Wenk
Journal:  Neurosci Lett       Date:  2010-06-10       Impact factor: 3.046

7.  Role of dopamine D2-like receptors and their modulation by adenosine receptor stimulation in the reinstatement of methamphetamine seeking.

Authors:  Tracey A Larson; Madeline C Winkler; Jacob Stafford; Sophia C Levis; Casey E O'Neill; Ryan K Bachtell
Journal:  Psychopharmacology (Berl)       Date:  2018-11-23       Impact factor: 4.530

8.  Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase.

Authors:  Maria José Diógenes; Raquel Neves-Tomé; Sergio Fucile; Katiuscia Martinello; Maria Scianni; Panos Theofilas; Jan Lopatár; Joaquim A Ribeiro; Laura Maggi; Bruno G Frenguelli; Cristina Limatola; Detlev Boison; Ana M Sebastião
Journal:  Cereb Cortex       Date:  2012-09-20       Impact factor: 5.357

9.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.